Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3,227 | 1 | 89.9% |
| Food and Beverage | $361.29 | 9 | 10.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma Global Development | $3,227 | 1 | $0 (2018) |
| Olympus America Inc. | $154.48 | 2 | $0 (2023) |
| Intuitive Surgical, Inc. | $77.90 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $49.10 | 1 | $0 (2023) |
| Eisai Inc. | $39.46 | 3 | $0 (2020) |
| Ethicon US, LLC | $25.45 | 1 | $0 (2022) |
| Veloxis Pharmaceuticals, Inc. | $14.90 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $203.58 | 3 | Olympus America Inc. ($154.48) |
| 2022 | $25.45 | 1 | Ethicon US, LLC ($25.45) |
| 2021 | $14.90 | 1 | Veloxis Pharmaceuticals, Inc. ($14.90) |
| 2020 | $39.46 | 3 | Eisai Inc. ($39.46) |
| 2019 | $77.90 | 1 | Intuitive Surgical, Inc. ($77.90) |
| 2018 | $3,227 | 1 | Astellas Pharma Global Development ($3,227) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/27/2023 | Olympus America Inc. | Olympus (Device) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Energy | ||||||
| 02/08/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $49.10 | General |
| Category: Gastroenterology | ||||||
| 02/06/2023 | Olympus America Inc. | VISERA ELITE II VIDEO SYSTEM CENTER OLYMPUS OTV-S300 (Device) | Food and Beverage | In-kind items and services | $124.52 | General |
| Category: Surgical Endoscopy | ||||||
| 11/29/2022 | Ethicon US, LLC | PROLENE (Device), ETHICON, Echelon; Endopath | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Sutures | ||||||
| 07/21/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Immunosuppresant | ||||||
| 03/12/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $11.40 | General |
| Category: Oncology | ||||||
| 02/07/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.03 | General |
| Category: Oncology | ||||||
| 01/10/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.03 | General |
| Category: Oncology | ||||||
| 04/12/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $77.90 | General |
| Category: SURGERY | ||||||
| 08/23/2018 | Astellas Pharma Global Development | ASTAGRAF XL (Drug) | — | In-kind items and services | $3,226.81 | Research |
| Study: Real-world study of once-daily, extended-release tacrolimus versus twice-daily, immediate-release tacrolimus in kidney transplantation clinical outcomes and healthcare resource utilization • Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Real-world study of once-daily, extended-release tacrolimus versus twice-daily, immediate-release tacrolimus in kidney transplantation clinical outcomes and healthcare resource utilization | Astellas Pharma Global Development | $3,227 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 188 | 258 | $857,385 | $109,189 |
| 2022 | 5 | 191 | 500 | $702,920 | $101,012 |
| 2021 | 4 | 97 | 230 | $123,735 | $35,448 |
| 2020 | 10 | 214 | 410 | $249,765 | $71,156 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 50360 | Transplantation of donor kidney | Facility | 2023 | 40 | 40 | $535,400 | $93,560 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 89 | $42,720 | $6,908 | 16.2% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2023 | 36 | 36 | $231,660 | $2,938 | 1.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 30 | 48 | $23,040 | $2,830 | 12.3% |
| 50327 | Preparation of donor kidney and veins for transplantation | Facility | 2023 | 17 | 17 | $19,805 | $1,708 | 8.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 28 | $4,760 | $1,245 | 26.1% |
| 50360 | Transplantation of donor kidney | Facility | 2022 | 33 | 33 | $427,456 | $78,868 | 18.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 65 | 338 | $57,460 | $12,118 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 60 | $18,000 | $4,892 | 27.2% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2022 | 29 | 29 | $180,621 | $2,343 | 1.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 23 | 29 | $6,568 | $1,583 | 24.1% |
| 50327 | Preparation of donor kidney and veins for transplantation | Facility | 2022 | 11 | 11 | $12,815 | $1,208 | 9.4% |
| 50360 | Transplantation of donor kidney | Facility | 2021 | 11 | 11 | $78,318 | $23,174 | 29.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 45 | 159 | $31,241 | $8,928 | 28.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 29 | 48 | $8,916 | $2,565 | 28.8% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2021 | 12 | 12 | $5,260 | $780.24 | 14.8% |
| 50360 | Transplantation of donor kidney | Facility | 2020 | 17 | 17 | $112,901 | $35,859 | 31.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 149 | $27,416 | $8,753 | 31.9% |
| 50605 | Insertion of stent in urinary duct (ureter) | Facility | 2020 | 17 | 17 | $44,880 | $7,711 | 17.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 82 | $21,812 | $6,973 | 32.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 22 | $11,418 | $3,589 | 31.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 29 | 29 | $8,651 | $2,441 | 28.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 17 | 17 | $7,763 | $2,082 | 26.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 24 | 45 | $5,895 | $1,896 | 32.2% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2020 | 17 | 17 | $6,494 | $1,047 | 16.1% |
About Dr. Kofi Atiemo, MD
Dr. Kofi Atiemo, MD is a Transplant Surgery healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2009. The National Provider Identifier (NPI) number assigned to this provider is 1467688812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kofi Atiemo, MD has received a total of $3,588 in payments from pharmaceutical and medical device companies, with $203.58 received in 2023. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "" ($3,227).
As a Medicare-enrolled provider, Atiemo has provided services to 690 Medicare beneficiaries, totaling 1,398 services with total Medicare billing of $316,804. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Transplant Surgery
- Other Specialties Transplant Surgery, Surgery
- Location New York, NY
- Active Since 05/29/2009
- Last Updated 06/26/2023
- Taxonomy Code 204F00000X
- Entity Type Individual
- NPI Number 1467688812
Products in Payments
- ASTAGRAF XL (Drug) $3,227
- VISERA ELITE II VIDEO SYSTEM CENTER OLYMPUS OTV-S300 (Device) $124.52
- Da Vinci Surgical System (Device) $77.90
- XIFAXAN (Drug) $49.10
- Lenvima (Drug) $39.46
- Olympus (Device) $29.96
- PROLENE (Device) $25.45
- Envarsus (Drug) $14.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Transplant Surgery Doctors in New York
Mr. Myron Schwartz, M.d, M.D
Transplant Surgery — Payments: $48,120
Lewis Teperman, M.d, M.D
Transplant Surgery — Payments: $36,454
Sasan Roayaie, Md, MD
Transplant Surgery — Payments: $35,035
Dr. Lloyd Ratner, Md, MD
Transplant Surgery — Payments: $33,745
Parissa Tabrizian, Md, MD
Transplant Surgery — Payments: $25,119
Dr. Ron Shapiro, Md, MD
Transplant Surgery — Payments: $23,050